Correlation Between UTI Asset and Par Drugs
Specify exactly 2 symbols:
By analyzing existing cross correlation between UTI Asset Management and Par Drugs And, you can compare the effects of market volatilities on UTI Asset and Par Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UTI Asset with a short position of Par Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of UTI Asset and Par Drugs.
Diversification Opportunities for UTI Asset and Par Drugs
Poor diversification
The 3 months correlation between UTI and Par is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding UTI Asset Management and Par Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Par Drugs And and UTI Asset is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UTI Asset Management are associated (or correlated) with Par Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Par Drugs And has no effect on the direction of UTI Asset i.e., UTI Asset and Par Drugs go up and down completely randomly.
Pair Corralation between UTI Asset and Par Drugs
Assuming the 90 days trading horizon UTI Asset Management is expected to generate 0.92 times more return on investment than Par Drugs. However, UTI Asset Management is 1.08 times less risky than Par Drugs. It trades about -0.2 of its potential returns per unit of risk. Par Drugs And is currently generating about -0.79 per unit of risk. If you would invest 111,150 in UTI Asset Management on November 28, 2024 and sell it today you would lose (13,350) from holding UTI Asset Management or give up 12.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
UTI Asset Management vs. Par Drugs And
Performance |
| Timeline |
| UTI Asset Management |
| Par Drugs And |
UTI Asset and Par Drugs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with UTI Asset and Par Drugs
The main advantage of trading using opposite UTI Asset and Par Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UTI Asset position performs unexpectedly, Par Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Par Drugs will offset losses from the drop in Par Drugs' long position.| UTI Asset vs. ROUTE MOBILE LIMITED | UTI Asset vs. SBI Life Insurance | UTI Asset vs. CSB Bank Limited | UTI Asset vs. RBL Bank Limited |
| Par Drugs vs. POWERGRID Infrastructure Investment | Par Drugs vs. Nalwa Sons Investments | Par Drugs vs. Mask Investments Limited | Par Drugs vs. Tube Investments of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |